Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Radiation for High-Risk Bone Metastases
NCT03523351Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- May 2018
- Primary completion
- Apr 2024
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Skeletal Related Events at 1 year. Started May 2018; status: completed.
Beyond the preview
Go deeper on NCT03523351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03523351.